are maintained regardless of acute changes in estimated glomerular filtration rate (eGFR) following treatment initiation in patients with chronic kidney disease (CKD) and type 2 diabetes (T2D).

Fibrate therapy may lower the risks of mortality and progression to end-stage kidney disease (ESKD), despite raising the risk for new onset stage 3 or higher chronic kidney disease (CKD), a new study ...

COVID-19 in children and adolescents is associated with adverse long-term kidney outcomes, such as chronic kidney disease (CKD).

Glargine U300 use was common, especially with increased CKD stages and baseline HbA1c levels among patients with type 2 diabetes.

eGFR was also analyzed as a prospectively ... was investigated in the ADI CKD (adenine-induced animal model of chronic kidney disease) model, a well-established animal model of CKD.

"This decision not only validates the strength of the phase-III PROTECT study results but also reinforces our deep commitment to this rare kidney disease ... on the eGFR chronic slope endpoint ...

“This decision not only validates the strength of the Phase 3 PROTECT Study results but also reinforces our deep commitment to this rare kidney disease ... on the eGFR chronic slope endpoint ...

European Commission converts conditional approval of FILSPARI (sparsentan) into standard marketing authorization for the treatment of IgA Nephropathy (IgAN) Decision follows positive recommendation ...

So in terms of pipeline, I think, you know, we our progress with filing Gamifant for HLH MAs and still disease ... the kidney in high percentage of patients, and the stabilization of EGFR at ...

Compare Dialysis Centers examined CDC data and other sources to explore kidney disease risk factors and why the condition has ...

Individuals who eat a proinflammatory diet have a higher likelihood of chronic kidney disease, according to a review published online.